Background
T-cell responses during chronic viral infections become exhausted, which is reflected by up-regulation of inhibitory receptors (iRs) and increased IL-10. We assessed the iRs (PD-1, programmed cell death protein 1, Tim-3, T-cell immunoglobulin and mucin domain-containing protein 3) and IL-10 mRNAs in peripheral blood mononuclear cells (PBMC) and their soluble analogs (sPD-1, sTim-3 and IL-10) in plasma in chronic HIV-1/HCV co-infection and explored the effect of HCV treatment on these markers. We also aimed to establish whether iR expression may be determined by the HCV CD8+ T-cell immunodominant epitope sequence.
Methods
Plasma and PBMC from 31 persons with chronic HIV-1/HCV coinfection from the Swiss HIV Cohort Study were collected before and after HCV treatment. As controls, 45 HIV-1 negative persons with chronic HCV infection were recruited. Exhaustion markers were assessed by ELISA in plasma, and by RT-qPCR in PBMC. Analysis of HCV HLA-A*02-restricted NS31073-1081, NS31406-1415 and HLA-A*01-restricted NS31436-1444 epitopes sequence was conducted by next-generation sequencing.
Results
The study revealed higher plasma sPD-1 (P = 0.0235), IL-10 (P = 0.002) levels and higher IL-10 mRNA in PBMC (P = 0.0149) in HIV-1/HCV coinfection. A decrease in plasma sPD-1 (P = 0.0006), sTim-3 (P = 0.0136) and IL-10 (P = 0.0003) and Tim-3 mRNA in PBMC (P = 0.0210) was observed following successful HCV treatment. Infection with the HLA-A*01-restricted NS31436-1444 ATDALMTGY prototype variant was related to higher sTim-3 levels than infection with ATDALMTGF escape variant (P = 0.0326).
Conclusions
The results underscore the synergistic effect of coinfection on exhaustion markers expression, their reduction following successful HCV treatment and imply that iR levels may operate on epitope-specific manner.